Skip to Content

Apriso Approval History

FDA Approved: Yes (First approved October 31, 2008)
Brand name: Apriso
Generic name: mesalamine
Dosage form: Extended-Release Capsules
Company: Salix Pharmaceuticals, Ltd.
Treatment for: Ulcerative Colitis

Apriso (mesalamine) is a once-daily, locally-acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis (UC) in adults.

Development History and FDA Approval Process for Apriso

DateArticle
Nov  3, 2008Approval Apriso Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide